Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Akanda Corp. (AKAN)

0.59   -0.023 (-3.8%) 09-21 12:22
Open: 0.601 Pre. Close: 0.6133
High: 0.63 Low: 0.57
Volume: 120,940 Market Cap: 2(M)

Technical analysis

as of: 2023-09-21 12:14:39 PM
Short-term rate:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Mid-term rate:       
Target: Six months: 0.95     One year: 1.22
Support: Support1: 0.43    Support2: 0.36
Resistance: Resistance1: 0.81    Resistance2: 1.04
Pivot: 0.68
Moving Average: MA(5): 0.68     MA(20): 0.63
MA(100): 0.72     MA(250): 1.54
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 22.2     %D(3): 35.5
RSI: RSI(14): 45.1
52-week: High: 6.34  Low: 0.43
Average Vol(K): 3-Month: 431 (K)  10-Days: 959 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AKAN ] has closed above bottom band by 26.8%. Bollinger Bands are 77.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.69 - 0.7 0.7 - 0.7
Low: 0.57 - 0.58 0.58 - 0.58
Close: 0.59 - 0.6 0.6 - 0.61

Company Description

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Headline News

Wed, 20 Sep 2023
Akanda announces signing of option to develop Canadian THC and ... - Seeking Alpha

Wed, 20 Sep 2023
Akanda Corp. Announces Signing of Option to Develop Canadian ... - Business Wire

Thu, 06 Jul 2023
Akanda Corp. Receives Nasdaq Notification Regarding Minimum ... - Business Wire

Mon, 29 May 2023
Akanda Corp. Announces Termination of Loan Agreement - Business Wire

Wed, 03 May 2023
Why Is Akanda (AKAN) Stock Up 114% Today? - InvestorPlace

Fri, 28 Apr 2023
Akanda Corp. Announces Loan Agreement - Business Wire

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 4 (M)
Shares Float 2 (M)
% Held by Insiders 24.4 (%)
% Held by Institutions 0.2 (%)
Shares Short 126 (K)
Shares Short P.Month 3 (K)

Stock Financials

EPS -3.42
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.76
Profit Margin (%) 0
Operating Margin (%) -760.7
Return on Assets (ttm) -53
Return on Equity (ttm) -66.7
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0.84
Sales Per Share 0.67
EBITDA (p.s.) -4.24
Qtrly Earnings Growth 0
Operating Cash Flow -11 (M)
Levered Free Cash Flow -2 (M)

Stock Valuations

PE Ratio -0.17
PEG Ratio 0
Price to Book value 0.07
Price to Sales 0.84
Price to Cash Flow -0.2

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.